An Open-label Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor PET Tracer 18F-JNJ-64413739

Trial Profile

An Open-label Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor PET Tracer 18F-JNJ-64413739

Recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs JNJ 54175446 (Primary) ; 18F-JNJ-64413739
  • Indications Major depressive disorder
  • Focus Diagnostic use; Pharmacokinetics
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 28 Jul 2017 Planned End Date changed from 14 Jul 2018 to 25 Apr 2018.
    • 28 Jul 2017 Planned primary completion date changed from 14 Jul 2018 to 25 Apr 2018.
    • 14 Apr 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top